Immediate testing for the presence of Coronavirus SARS-CoV-2 is currently being performed at Red Arrow Analytical Laboratories utilizing two molecular platforms that have received FDA Emergency Use Authorization to detect SARS-CoV2 viral nucleic acid material within respiratory specimens.
Red Arrow Analytical laboratories offers state of the art reverse transcription polymerase chain reaction (RT-PCR) technology for molecular diagnostic screening of SARS-CoV-2 viral DNA. RT-PCR is the primary diagnostic method for COVID-19. With a brand-new, fully automated, scalable system, Red Arrow Analytical brings a trouble-free solution to the COVID-19 market.
Molecular diagnostic screening by RT-PCR is a process of amplifying a small amount of DNA into amount that are easily detectable. A nasopharyngeal swab, oropharyngeal swab, saliva, or sputum sample is taken from the patient. Genetic and protein building blocks are added to the sample to allow for the amplification of the viral DNA. The sample is then put through an automated extraction procedure where the SARS-CoV-2 DNA is removed from the cellular material.
The sample is then analyzed in real-time on a thermocycler (RT-PCR) that uses temperature to facilitate a three-step amplification process. This process of denaturation (separation of the DNA strand into two single strands), annealing (binding of primers to the complementary single DNA strands), and extension (using polymerase to add DNA fragment known as dNTPs to create new DNA strands) are repeated for an exponential increase of DNA until the amount of DNA is detectable using fluorescence. Red Arrow Analytical Laboratories uses two SARS-CoV-2 specific viral markers to ensure accuracy and reliability in testing.
Our proprietary LIMS system allows for us to deliver an exceptional electronic experience. We have advanced reporting and interpretation of sample results. All results are compatible with HL7 mapping.